Literature DB >> 9223508

Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA.

R Sun1, T A Spain, S F Lin, G Miller.   

Abstract

Interconversion between the linear genome of Epstein-Barr virus (EBV) present in virions and intracellular circular EBV DNA is a novel DNA recombination process. A previously characterized DNA binding activity called terminal repeat or tandem repeat binding protein (TRBP) was found to recognize several G-rich recombinogenic sequences in the EBV genome and in cellular DNA. TRBP was also found to be an autoantigen recognized by sera from certain patients with undifferentiated connective-tissue disorders. Here the transcription factor Sp1 has been identified as a component of TRBP and has been shown to be an autoantigen. Sp1 bound to recombination junctions of EBV DNA, such as those in the terminal repeats and in the large internal repeats, as well as to recombinogenic regions of cellular DNA, such as variable-number tandem repeats and switch regions of the immunoglobulin genes. We defined the ends of the linear EBV genome present in virions and showed that Sp1 binds to the sequence (GGGGTGGGGCATGGG) within EBV terminal repeats at the precise locus of interconversion of linear and circular viral DNA. Sp1 may be involved in DNA recombination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223508      PMCID: PMC191874     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product.

Authors:  K O Hartley; D Gell; G C Smith; H Zhang; N Divecha; M A Connelly; A Admon; S P Lees-Miller; C W Anderson; S P Jackson
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

2.  Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.

Authors:  H Sato; T Takimoto; S Tanaka; J Tanaka; N Raab-Traub
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  The RAG1 and RAG2 proteins establish the 12/23 rule in V(D)J recombination.

Authors:  D C van Gent; D A Ramsden; M Gellert
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

Review 4.  The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.

Authors:  U A Gompels; J Nicholas; G Lawrence; M Jones; B J Thomson; M E Martin; S Efstathiou; M Craxton; H A Macaulay
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

5.  A human RNA polymerase II complex associated with SRB and DNA-repair proteins.

Authors:  E Maldonado; R Shiekhattar; M Sheldon; H Cho; R Drapkin; P Rickert; E Lees; C W Anderson; S Linn; D Reinberg
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

6.  Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA.

Authors:  E S Mocarski; B Roizman
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

7.  Inhibition of generation of authentic genomic termini of herpes simplex virus type 1 DNA in temperature-sensitive mutant BHK-21 cells with a mutated CCG1/TAF(II)250 gene.

Authors:  K Umene; T Nishimoto
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.

Authors:  K T Jeang; S D Hayward
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

9.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.

Authors:  T Blunt; N J Finnie; G E Taccioli; G C Smith; J Demengeot; T M Gottlieb; R Mizuta; A J Varghese; F W Alt; P A Jeggo; S P Jackson
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

10.  Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells.

Authors:  R Sun; E Grogan; D Shedd; A F Bykovsky; V M Kushnaryov; S E Grossberg; G Miller
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

View more
  7 in total

1.  Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.

Authors:  Jianhong Hu; Rolf Renne
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.

Authors:  Kazufumi Ikuta; Mingyu Ding; Fangfang Zhang; John W Sixbey; Rona S Scott
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative epstein-barr virus.

Authors:  R Feederle; C Shannon-Lowe; G Baldwin; H J Delecluse
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments.

Authors:  Ayumi Kudoh; Satoko Iwahori; Yoshitaka Sato; Sanae Nakayama; Hiroki Isomura; Takayuki Murata; Tatsuya Tsurumi
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

5.  Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68.

Authors:  Hongyu Deng; Julia T Chu; No-Hee Park; Ren Sun
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.

Authors:  David H Dreyfus
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

7.  Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo.

Authors:  Clinton R Paden; J Craig Forrest; Scott A Tibbetts; Samuel H Speck
Journal:  PLoS Pathog       Date:  2012-09-06       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.